Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 190-195, January 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sani, B. P.
Right arrow Articles by Schiff, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sani, B. P.
Right arrow Articles by Schiff, L. J.

Relationship between Binding Affinities to Cellular Retinoic Acid-binding Protein and Biological Potency of a New Series of Retinoids

Brahma P. Sani1, Marcia I. Dawson2, Peter D. Hobbs, Rebecca L-S. Chan and Leonard J. Schiff3

Kettering Meyer Laboratory, Southern Research Institute, Birmingham, Alabama 35255-5305 [B. P. S.]; Life Sciences Division, SRI International, Menlo Park, California 94025 [M. I. D., P. D. H., R. L-S. C.]; and IIT Research Institute, Chicago, Illinois 60616 [L. J. S.]

Binding affinities of a new and unusual series of retinoic acid analogues to cellular retinoic acid-binding protein, a possible mediator of their biological function in the control of differentiation and tumorigenesis, and to serum albumin, their plasma transport protein, were determined. Also, biological activity of these retinoids in the reversal of keratinization in hamster tracheal organ cultures was assessed and compared with their binding affinities. Analogues that possessed high biological activity showed high binding efficiency to cellular retinoic acid-binding protein. Those that were biologically less active were poor binders to the binding protein. Three retinoids, 4657-57, 3920-59, and 4445-75, which showed 90 to 100% binding efficiency of that of retinoic acid for cellular retinoic acid-binding protein expressed high biological activity detectable in the range of 10-10 M as against 10-11 M for retinoic acid. The correlation noticed in these two activities not only enhances the confidence in the two assay procedures but also paves the way for design and development of potential chemopreventive agents. No apparent differences were observed in the binding affinities of the retinoids to binding proteins of a normal tissue or a tumor tissue. No correlation existed between the binding affinities of these retinoids to serum albumin and their biological activity. Structure-activity relationships of the retinoids in relation to their binding affinities and biological activities have been discussed.

1 Recipient of Biomedical Research Support Grant 2SO7 RR0567-05 from the NIH. To whom requests for reprints should be addressed, at Biochemistry Department, Southern Research Institute, P.O. Box 55305, Birmingham, Ala. 35255-5305.

2 Recipient of NIH USPHS Grant CA30512 and Contract NO1-CP-5600.

3 Recipient of Contract NO1-CP-5610 from the Division of Cancer Cause and Prevention, National Cancer Institute, NIH.

Received 6/ 3/83. Accepted 10/ 7/83.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.